Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$74.62 -1.11 (-1.47%)
As of: Sep 30, 2026 · 3:59 PM EDT

Kiniksa Pharmaceuticals International (KNSA) FCF Margin (2021 - 2026)

Updated

Kiniksa Pharmaceuticals International (KNSA) posted FCF Margin of 19.10% for Q2 2026, up 1.29 percentage points from 17.81% a year earlier but down 4.25 percentage points from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) FCF Margin (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, FCF Margin at Kiniksa Pharmaceuticals International was 21.74%, up 9.18 percentage points year-over-year; for FY2025, it was 20.13%, up 14.13 percentage points from FY2024.

  • Annual FCF Margin has increased for four consecutive years, with a four-year change of +348.88 percentage points (FY2021 to FY2025).
  • In prior years, Kiniksa Pharmaceuticals International's FCF Margin was 6.00% in FY2024 (+1.13 pp), 4.87% in FY2023 (+2.28 pp), 2.59% in FY2022 (+331.34 pp) and -328.75% in FY2021.
  • Quarterly FCF Margin has run from a low of -236.13% in Q3 2021 to a high of 62.57% in Q3 2022 over five years.
  • On a year-over-year basis, FCF Margin has increased in each of the last seven quarters, with an average year-over-year change of +5.87 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for FCF Margin in the past five years was Q2 2022, with a gain of 475.17 percentage points; the weakest was Q3 2023, with a drop of 37.26 percentage points.
  • According to Business Quant data, FCF Margin for the three prior quarters was 23.35% (Q1 2026), 26.35% (Q4 2025) and 18.25% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.82%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 18.33%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 26.96%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 43.05%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 34.72%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.70%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 30.39%
10 Kiniksa Pharmaceuticals International 11.81 Bn 10.55 Bn 220.03 Mn 19.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.10%
Mar 31, 2026 23.35%
Dec 31, 2025 26.35%
Sep 30, 2025 18.25%
Jun 30, 2025 17.81%
Mar 31, 2025 16.13%
Dec 31, 2024 15.16%
Sep 30, 2024 -1.99%
Jun 30, 2024 4.76%
Mar 31, 2024 4.89%
Dec 31, 2023 5.12%
Sep 30, 2023 25.31%
Jun 30, 2023 -5.28%
Mar 31, 2023 -8.88%
Dec 31, 2022 -18.65%
Sep 30, 2022 62.57%
Jun 30, 2022 -29.01%
Mar 31, 2022 -114.47%
Dec 31, 2021 -102.08%
Sep 30, 2021 -236.13%
API Access

Kiniksa Pharmaceuticals International FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEY